Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  PerkinElmer, Inc.    PKI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

PerkinElmer, Inc. : PerkinElmer Board Declares Quarterly Dividend

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/25/2013 | 10:10pm CEST

The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on January 25, 2013. This dividend is payable on May 10, 2013, to all shareholders of record at the close of business on April 19, 2013.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $1.9 billion in 2011, has about 7,400 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Investor Relations:
PerkinElmer, Inc.
Tommy J. Thomas, 781-663-5889
[email protected]
or
Media Contact:
PerkinElmer, Inc.
Stephanie R. Wasco, 781-663-5701
[email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PERKINELMER, INC.
09/21 PERKINELMER : and In-Depth Genomics Team Up for Whole Genome Sequencing Diagnost..
09/18 PERKINELMER, INC. (NYSE : PKI) Files An 8-K Departure of Directors or Certain Of..
09/15 PERKINELMER INC : Change in Directors or Principal Officers (form 8-K)
09/15 PERKINELMER : Announces Future Retirement of Andy Wilson, Chief Financial Office..
09/14 PERKINELMER : Extends Clinical Whole Genome Sequencing Services
09/12 PERKINELMER : Extends Clinical Whole-Genome Sequencing Services
09/09 PERKINELMER : Extends Clinical Whole Genome Sequencing Services
09/06 PERKINELMER : Combine Solicitation - US EPA - Opera Phenix HCSS
08/31 PERKINELMER : hosts Medical Genomics Seminars in India
08/28 PERKINELMER : to Present at Morgan Stanley Global Healthcare Conference
More news
News from SeekingAlpha
08/03 PerkinElmer (United States) (PKI) Q2 2017 Results - Earnings Call Transcript
08/03 PerkinElmer EPS in-line, misses on revenue
08/02 Notable earnings after Thursday?s close
07/24 PerkinElmer declares $0.07 dividend
06/22 PerkinElmer - EUROIMMUN Looks Like A Very Decent Addition
Financials ($)
Sales 2017 2 230 M
EBIT 2017 432 M
Net income 2017 321 M
Debt 2017 271 M
Yield 2017 0,41%
P/E ratio 2017 24,66
P/E ratio 2018 25,25
EV / Sales 2017 3,49x
EV / Sales 2018 3,27x
Capitalization 7 513 M
Chart PERKINELMER, INC.
Duration : Period :
PerkinElmer, Inc. Technical Analysis Chart | PKI | US7140461093 | 4-Traders
Technical analysis trends PERKINELMER, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 70,4 $
Spread / Average Target 3,3%
EPS Revisions
Managers
NameTitle
Robert F. Friel Chairman, President & Chief Executive Officer
Frank Anders Wilson Chief Financial Officer & Senior Vice President
Nicholas A. Lopardo Independent Director
Alexis Platon Michas Lead Independent Director
Patrick J. Sullivan Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PERKINELMER, INC.30.78%7 513
THERMO FISHER SCIENTIFIC INC.33.18%75 111
DANAHER11.02%60 285
BOSTON SCIENTIFIC CORPORATION33.33%39 586
ROYAL PHILIPS21.62%39 413
INTUITIVE SURGICAL62.45%38 322